World leaders pledge to tackle superbugs, but set no specific targets
(By Helen Branswell for ST A T) C ountries from around the world agreed Wednesday to take concerted efforts to
Read More
Part D/Prescription Drugs
Mylan CEO Claims EpiPens Aren’t As Profitable As Everyone Thinks
(By Alison Kodjak for NPR) The drug company that makes the EpiPen says it isn’t nearly as profitable as many
Read MoreHow Much Has Medicare Spent on the EpiPen Since 2007?
(By Juiette Cubanski, Tricia Neuman, and Anthony Damico for Kaiser Family Foundation) The latest example of high and rising prescription
Read MoreVeterans Courted In California’s Ballot Fight Over Curbing Drug Prices
(By Pauline Bartolone for California Healthline) Once a month at the Veterans of Foreign Wars building in Sacramento, a couple
Read MoreCalifornia governor decries ‘predatory’ pricing as he signs law to make EpiPen available
(By Ed Silverman for ST A T) For all intents and purposes, California Governor Jerry Brown held his nose Friday
Read MoreSarepta to charge $300K for Duchenne drug. ‘We tried to be reasonable,’ CEO says
(By Ed Silverman for ST A T) T he newly approved 1 Sarepta Therapeutics drug for Duchenne muscular dystrophy 2
Read MoreAs profitable fentanyl industry expands in China, US negotiates to halt the deadly trade
(By Kathleen McLaughlin for ST A T) B EIJING — Top American and Chinese enforcement officials are negotiating how to
Read MoreNilotinib: Is it the Cure for Lewy Body Dementia?
Don Carano believes there is a cure for Lewy Body Dementia but medical experts disagree and say more research is
Read MoreFDA approves Sarepta’s controversial drug for Duchenne muscular dystrophy
(By Ed Silverman for ST A T) he Food and Drug Administration on Monday approved 1 a controversial drug to
Read MoreGlobal leaders are set to put superbugs on the world stage
(Helen Branswell for ST A T) H eads of state from around the globe will gather this week to try
Read More